Status:
COMPLETED
Multiple Sclerosis in the Elderly: Epidemiology, Clinical and MRI Characteristics
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Observatoire Français de la sclérose en plaques (OFSEP)
Novartis
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
75-77 years
Brief Summary
Little is known about old MS patients. In a previous work, systematic search in Bordeaux, Strasbourg and Dijon university hospital regional MS center databases European Database for Multiple Sclerosis...
Detailed Description
75 to 77 years old MS patients whose disease began at 65 years old or earlier will be retrieved from the "Observatoire français de la sclérose en plaques" (OFSEP) which includes more than 50 000 MS pa...
Eligibility Criteria
Inclusion
- Patients with McDonald 2001, 2005 or 2010 criteria of multiple sclerosis 75 to 77 years old MS patients at the time of inclusion
- Patients whose beginning of MS was before 65 years old or 65 years old
- Patients who signed OFSEP 's consent
Exclusion
- Patients whose clinical data cannot be entered or for whom too much clinical data are missing
- Alive patients older than 77 years or younger than 75 years the day of the inclusion in the study
- Patients died before 65 years old
Key Trial Info
Start Date :
September 21 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 23 2020
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT03854123
Start Date
September 21 2018
End Date
September 23 2020
Last Update
February 3 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux - Pellegrin - service de neurologie
Bordeaux, France
2
Hôpital neurologique - Pierre Wertheimer
Bron, France
3
CHU de Rennes - service de neurologie
Rennes, France